Whalesbook
Regulatory Probe Concludes Long-Standing Healthcare Inquiry
The Competition Commission of India (CCI) has closed a ten-year investigation into twelve Delhi hospitals suspected of abusing their market dominance. The CCI found insufficient evidence to prove that the hospitals had acted unfairly. This decision concludes a lengthy inquiry into the hospitals' pricing for consumables, medicines, and medical devices.
Insufficient Evidence for Anti-Competitive Claims
The case was closed after the CCI reviewed reports from its Director General (DG). It is uncommon for the CCI to dismiss cases outright when initial findings suggest possible competition violations. Typically, cases with initial evidence of wrongdoing are investigated further.
Hospitals Under Scrutiny
The hospitals involved in the investigation were Max Super Specialty Hospital (Patparganj, Saket, and Shalimar Bagh), BLK Max Super Specialty Hospital, Max Multi Specialty Centre (Panchsheel Park and Pitampura), Fortis Flt. Lt. Rajan Dhall Hospital, Fortis Escorts Institute and Research Centre Ltd., Sir Ganga Ram Hospital, Indraprastha Medical Corporation Ltd. (Indraprastha Apollo Hospital), St. Stephen’s Hospital Delhi, and Batra Hospital & Medical Research Centre.
Legal Standard for Excessive Pricing Not Met
The investigation began with a complaint and included probes ordered in November 2015 and August 2018. The DG submitted revised reports in September 2024. The CCI stated that the evidence did not meet the legal criteria for abuse of dominance. The DG had found potential violations based on 'higher prices' and 'significant profit margins.' However, the CCI clarified that under Section 4 of the Competition Act, a price must be both excessive and unfair. The DG failed to prove unfairness, incorrectly equating it with mere excessiveness, which led to the case's dismissal.
Market Context and Healthcare Costs
This ruling comes as discussions on healthcare costs and regulation in India continue. While the CCI cleared these hospitals of anti-competitive practices, the overall issue of healthcare affordability remains a concern for consumers. Other hospitals not involved in this case continue to operate under current market conditions. The CCI's decision may offer clarity to the accused hospitals, though the decade-long scrutiny could still affect their public image.